Rapid fFN
Device
Gen-Probe, Inc.
Total Payments
$213,450
Transactions
3
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $213,450 | 3 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $213,450 | 3 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Quantitative fFN at 36 weeks to Delivery and Quantitative fFn Before Induction: A Feasibility Study | Gen-Probe, Inc. | $193,560 | 0 |
| The Clinical Impact of Implementation of Fetal Fibronectin Testing | Gen-Probe, Inc. | $19,890 | 0 |
Top Doctors Receiving Payments for Rapid fFN
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Birmingham, AL | $213,450 | 3 |
Ad
Manufacturing Companies
- Gen-Probe, Inc. $213,450
Product Information
- Type Device
- Total Payments $213,450
- Total Doctors 0
- Transactions 3
About Rapid fFN
Rapid fFN is a device associated with $213,450 in payments to 0 healthcare providers, recorded across 3 transactions in the CMS Open Payments database. The primary manufacturer is Gen-Probe, Inc..
Payment data is available from 2018 to 2018. In 2018, $213,450 was paid across 3 transactions to 0 doctors.
The most common payment nature for Rapid fFN is "Unspecified" ($213,450, 100.0% of total).
Rapid fFN is associated with 2 research studies, including "Quantitative fFN at 36 weeks to Delivery and Quantitative fFn Before Induction: A Feasibility Study" ($193,560).